Literature DB >> 13005661

Isonicotinic acid hydrazide in tuberculosis in man.

W MCDERMOTT, C MUSCHENHEIM, C CLARK, D F ELMENDORF, W U CAWTHON.   

Abstract

Entities:  

Keywords:  NICOTINIC ACID ISOMERS/therapeutic use; TUBERCULOSIS, MILIARY/therapy; TUBERCULOSIS, PULMONARY/therapy

Mesh：

Substances：

Year:  1952        PMID： 13005661

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN： 0066-9458


× No keyword cloud information.
  2 in total

1.  Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.

Authors:  Andreas Diacon; Sachiko Miyahara; Rodney Dawson; Xin Sun; Evelyn Hogg; Kathleen Donahue; Michael Urbanowski; Veronique De Jager; Courtney V Fletcher; Richard Hafner; Susan Swindells; William Bishai
Journal:  Lancet Microbe       Date:  2020-06-08

2.  Synthesis of ramariolide natural products and discovery of their targets in mycobacteria.

Authors:  Johannes Lehmann; Johannes Richers; Alexander Pöthig; Stephan A Sieber
Journal:  Chem Commun (Camb)       Date:  2016-12-20       Impact factor: 6.222
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.